Collage Venture Partners
Overview
A venture capital firm founded in 2021 and based in Miami Beach, Florida. The firm primarily invests in the life sciences sector, including areas like drug discovery, surgical devices, HealthTech, and High Tech, with a focus on Series A rounds in United States-based startups.
Portfolio Companies
7
Website
collagepartners.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Evecxia Therapeutics | Sep 2025 | VC Round | Lead |
| Bond Biosciences | Jan 2022 | Series B | Lead |
| Retension Pharmaceuticals | Aug 2025 | Series B | Co-investor |
| Response Pharmaceuticals | Nov 2022 | Series A | Co-investor |
| Cyana Therapeutics | Dec 2025 | Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Collage Venture Partners based?
Collage Venture Partners is headquartered in Miami Beach, Florida, United States.
When was Collage Venture Partners founded?
Founding year information for Collage Venture Partners is not publicly available.
How many portfolio companies does Collage Venture Partners have?
Collage Venture Partners has 7 portfolio companies in Caplight's dataset.
What are some companies in Collage Venture Partners's portfolio?
Portfolio companies visible on Caplight include Evecxia Therapeutics, Bond Biosciences, Retension Pharmaceuticals, Response Pharmaceuticals, Cyana Therapeutics.
What was Collage Venture Partners's most recent investment shown here?
Collage Venture Partners's most recent investment in this portfolio sample was in Cyana Therapeutics in 2025.
What sectors does Collage Venture Partners focus on?
Collage Venture Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Collage Venture Partners focus on?
Collage Venture Partners typically invests at the Early stage.